Related Experiment Video
Updated: May 24, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
[Staphylococcus aureus (methicillin-resistant S. aureus: MRSA)]
Tatsuo Yamamoto1, Tomomi Takano, Akihito Nishiyama
1Division of Bacteriology, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences.
Abstract:
Before antibiotic development, Staphylococcus aureus was a cause of serious invasive infections such as sepsis and meningitis and claimed many lives. However, even after antibiotic development, S. aureus posed a new threat as a major nosocomial pathogen, changing it to methicillin-resistant S. aureus (MRSA) since 1961. This year marks the 50th anniversary of the first report on MRSA. Today, there are two classes of MRSA spreading in hospitals and the community. The United States experienced invasive MRSA epidemics in 2005, and the latter MRSA (named CA-MRSA), especially USA300, affected the entire United States. As a countermeasure, guidelines for the management of MRSA infections were prepared in 2011. In Japan, there are people who are suffering from "hidden" epidemics in the community, falling behind in fighting CA-MRSA. We summarized current epidemic MRSA and infections.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant threat, evolving into hospital- and community-acquired strains. This review details MRSA epidemics and infections, particularly in Japan.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Context:
- Staphylococcus aureus historically caused severe infections before antibiotics.
- Methicillin-resistant Staphylococcus aureus (MRSA) emerged as a major nosocomial pathogen in 1961.
- Two main MRSA classes now circulate globally, including community-associated MRSA (CA-MRSA) strains like USA300.
Purpose:
- To summarize the current landscape of epidemic MRSA and associated infections.
- To highlight the challenges posed by CA-MRSA, particularly in Japan.
- To provide an overview of MRSA epidemiology and management strategies.
Summary:
- MRSA, a significant threat since 1961, has evolved into distinct hospital- and community-acquired strains.
- Invasive MRSA epidemics, notably USA300, have impacted the United States, leading to management guidelines in 2011.
- Japan faces a 'hidden' epidemic of CA-MRSA, necessitating focused attention and countermeasures.
Impact:
- Informs healthcare professionals about evolving MRSA threats.
- Guides public health strategies for combating MRSA infections.
- Contributes to the understanding of global MRSA epidemiology and control.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance
Mismatch Repair
